维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Schellens I"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Viral replication capacity as a correlate of HLA-B57/B5801-associated nonprogressive HIV-1 infection显示文摘	Navis M Schellens I van Baarle D	2007	J Immunol2007，179，5：	1
2	Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer显示文摘	Bosch T M Meijerman I Beijnen J H Schellens J H	2006	Clin Pharmacokinet2006，45，3：	1
3	Herb-drug interactions in oncology: focus on mechanisms of induction 显示文摘	Meijerman I Beijnen JH Schellens JH	2006	Oncologist2006，11，7：	1
4	Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer显示文摘	Meijerman I Beijnen J H Schellens J H	2008	Cancer Treatment Reviews2008，34，6：	1
5	Quantitative assay for six potential breast cancer biomarker peptides in human serum by liquid chromatography coupled to tandem mass spectrometry显示文摘	Van den Broek I Sparidans R W Schellens J H	2010	Chromatogr B Analyt Technol Biomed Life Sci2010，878，56：	1
6	Rapid Communications in Mass Spectrometry显示文摘	van den Broek I Sparidans R W Schellens J H M Beijnen J H	2010	24(13):18422010，24，13：	1
7	Herb-drug interactions in ontology: focus on mechanisms of induction 显示文摘	Meijerman I Beijnen J H Schellens J H M	2006	Oncologist2006，11，：	1
8	A phase Ⅰ and pharmacological study of MK-1775,a Weel tyrosine kinase inhibitor,in both monotherapy and in combination with gemcit-abine,cisplatin,or carboplatin in patients with advanced solid tumors显示文摘	SCHELLENS J H LEIJEN S SHAPIRO G I	2009	J Clin Oncol2009，27，15：	1
9	Herb-drug interactions in oncology:focus on mechanisms of induction显示文摘	MEIJERMAN I BEIJNEN JH SCHELLENS JH	2006	Oncologist2006，11，7：	1
10	Combined action and regulation of phase Ⅱ enzymes and multidrug resistance proteins in multidrug resistance in cancer显示文摘	Meijerman I Beijnen JH Schellens JH	2008	Cancer Treat Rev2008，34，6：	1
11	Combined action and regulation of phase Ⅱ enzymes and multidrug resistance proteins in multidrug resistance in cancer显示文摘	Meijerman I Beijnen JH Schellens JH	2008	Cancer Treat Rev2008，34，6：	1
12	Expression of the breast cancer resistance protein in breast cancer显示文摘	Faneyte I F Kristel P M Maliepaard M Scheffer G L Seheper R J Schellens J H	2002	Clin Cancer Res2002，8，：	1
13	Combined actionand regulation of phase D enzymes and multidrug resis-tance proteins in multidrug resistance in cancer 显示文摘	Meijerman I Beijnen JH Schellens JH	2008	Can-cer Treatment Reviews2008，34，6：	1
14	Sensitive liquid chromatography/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples 显示文摘	Van den Brock I Sparidans RW Schellens JH	2010	Rapid Commun Mass Spectrom2010，24，13：	1
15	Herb-drug interactions in oneology:focus on mechanisms of induction显示文摘	Meijerman I Beijnen J H Schellens J H	2006	Oneologist2006，11，7：	1
16	An update on in vitro test methods in human hepatic drug biotransformation research : pros and cons显示文摘	Brandon EF Raap CD Meijerman I Beijnen JH Schellens JH	2003	Toxicol Appl Pharmacol2003，189，3：	1
17	Combined action and regulation of phase Ⅱ enzymes and muhidrug resistance proteins in muhidrug resistance in cancer显示文摘	MEIJERMAN I BEIJNEN J H SCHELLENS J H	2008	Cancer Treat Rev2008，34，6：	1
18	Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer显示文摘	Meijerman I Beijnen J H Schellens J H	2008	Cancer Treat Rev2008，34，：	1
19	Herb--drug interactions in oncology: focus on mechanisms of induction 显示文摘	Meijerman I Beijnen J H Schellens J H M	2006	Oncologist2006，11，：	1
20	A phase and pharmacological study of MK-1775,a Wee1 tyrosine kinase inhibitor,in both monotherapy and in combination with gemcitabine,cisplatin,or carboplatin in patients with advanced solid tumors显示文摘	Schellens J H Leijen S Shapiro G I	2009	J Clin Oncol2009，27，15：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示